<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2024.547</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-2284</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Maternal gut microbiome and its impact on developing idiopathic late fetal growth retardation</article-title><trans-title-group xml:lang="ru"><trans-title>Состояние материнского кишечного микробиома и его влияние на развитие синдрома идиопатической поздней задержки роста плода</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2006-0110</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Железова</surname><given-names>М. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhelezova</surname><given-names>M. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Железова Мария Евгеньевна, д.м.н., проф.</p><p>420012 Казань, ул. Карла Маркса, д. 74</p></bio><bio xml:lang="en"><p>Maria E. Zhelezova, MD, Dr Sci Med, Prof.</p><p>74 Karl Marks Str., Kazan 420012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2242-216X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бектур</surname><given-names>Б. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Bektur</surname><given-names>B. К.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Бектур Бегимай кызы</p><p>420110 Казань, ул. Братьев Касимовых, д. 40а</p></bio><bio xml:lang="en"><p>Begimai Bektur kyzy, MD.</p><p>40a Brothers Kasimov Str., Kazan 420110</p></bio><email xlink:type="simple">bekturbegimai@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0999-4374</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мальцева</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Maltseva</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мальцева Лариса Ивановна, д.м.н., проф</p><p>Казань 420015, ул. Бутлерова, д. 36</p></bio><bio xml:lang="en"><p>Larisa I. Maltseva, MD, Dr Sci Med, Prof.</p><p>36 Butlerova Str., Kazan 420015</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9119-559X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шарипова</surname><given-names>Р. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Sharipova</surname><given-names>R. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шарипова Резеда Ильнуровна, к.м.н.</p><p>420012 Казань, ул. Карла Маркса, д. 74</p></bio><bio xml:lang="en"><p>Rezeda I. Sharipova, MD, PhD</p><p>74 Karl Marks Str., Kazan 420012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6668-0554</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шакирзянова</surname><given-names>Д. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Shakirzyanova</surname><given-names>D. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шакирзянова Дана Булатовна</p><p>420012 Казань, ул. Карла Маркса, д. 74</p></bio><bio xml:lang="en"><p>Dana B. Shakirzyanova</p><p>74 Karl Marks Str., Kazan 420012</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Казанский (Приволжский) федеральный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan (Volga Region) Federal University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ООО «Клиника Нуриевых»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nuriev Clinic LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Казанская государственная медицинская академия – филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical Academy – Branch of the Russian Medical Academy of Continuing Professional Education, Health Ministry of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>10</day><month>01</month><year>2025</year></pub-date><volume>18</volume><issue>6</issue><fpage>788</fpage><lpage>799</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Zhelezova M.E., Bektur B.К., Maltseva L.I., Sharipova R.I., Shakirzyanova D.B., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Железова М.Е., Бектур Б.К., Мальцева Л.И., Шарипова Р.И., Шакирзянова Д.Б.</copyright-holder><copyright-holder xml:lang="en">Zhelezova M.E., Bektur B.К., Maltseva L.I., Sharipova R.I., Shakirzyanova D.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/2284">https://www.gynecology.su/jour/article/view/2284</self-uri><abstract><sec><title>Aim</title><p>Aim: to analyze a rectal microbiome composition in pregnant women and assess its potential impact on developing of idiopathic late fetal growth retardation (FGR) syndrome.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. We analyzed a course of pregnancy and labour in 80 pregnant women: main group consisted of 40 pregnant women with FGR, control group – of 40 healthy pregnant women. The analysis of the intestinal microbiota in 53 pregnant women (25 pregnant women with late FGR and 28 healthy pregnant women) was carried out by using nitrogenous base sequencing in the 16S ribosomal RNA (rRNA) genes.</p></sec><sec><title>Results</title><p>Results. Analyses of the gut microbiome composition in pregnant women in study groups revealed significant differences particularly showing a 1.0 % increase in the proportion of Clostridiales Ruminococcaceae Oscillospira that correlated with a 331.7 g increase in neonatal weight gain; a 1.0 % increase in the level of Coriobacteriales Coriobacteriaceae Collinsella was associated with a 476.2 g decrease in neonatal weight gain. The Firmicutes/Bacteroides ratio was 2,0 and 3.6 in main and control group (p = 0.02), respectively, which may suggest about a microbiological dysbiosis with putative pathophysiological outcomes. A significant association between elevated leucocyte counts (in the absence of other manifestations of inflammatory processes) and the probability of FGR development was found. A white blood cell count ≥ 11.05×109/L predicted the risk of FGR with a sensitivity of 60.6 % and a specificity of 79.2 %. Also, erythrocyte sedimentation rate level of ≥ 41.5 mm/hour was associated with increased FGR risk, demonstrating a sensitivity of 85.7 % and specificity of 70.6 %.</p></sec><sec><title>Conclusion</title><p>Conclusion. It can be concluded that gut dysbiosis may play a role in development of late idiopathic FGR. A negative correlation between a decreased Firmicutes/Bacteroides ratio as well as higher Actinobacteria proportion and fetal birth weight was found.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Цель</title><p>Цель: изучить состав микробиома прямой кишки беременных и оценить его возможное влияние на развитие синдрома идиопатической поздней задержки роста плода (ЗРП).</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен анализ течения беременности и родов 80 беременных. Основную группу составили 40 беременных с ЗРП, контрольную группу – 40 здоровых беременных. Анализ микробиоты кишечника у 53 беременных (25 беременных с поздней ЗРП и 28 здоровых беременных) проведен с использованием секвенирования азотистых оснований в генах 16S рибосомальной РНК (рРНК).</p></sec><sec><title>Результаты</title><p>Результаты. Анализ микробиомного состава кишечника беременных в исследуемых группах выявил значительные различия, имеющие клиническое значение. В частности, увеличение пропорции Clostridiales Ruminococcaceae Oscillospira на 1,0 % коррелировало с приростом массы тела новорожденных на 331,7 г; повышение уровня Coriobacteriales Coriobacteriaceae Collinsella на 1,0 % ассоциировалось со снижением массы тела новорожденных на 476,2 г. Отношение Firmicutes к Bacteroides составило 2,0 в основной группе и 3,6 в контрольной группе (р = 0,02), что может свидетельствовать о микробиологическом дисбиозе с возможными патофизиологическими последствиями. Установлена значимая связь между повышенным уровнем лейкоцитов (при отсутствии других проявлений воспалительных процессов) и вероятностью развития синдрома ЗРП. При лейкоцитозе ≥ 11,05×109/л риск ЗРП прогнозируется с чувствительностью 60,6 % и специфичностью 79,2 %.Также скорость оседания эритроцитов ≥ 41,5 мм/час ассоциировалась с повышенным риском ЗРП, демонстрируя чувствительность 85,7 % и специфичность 70,6 %.</p></sec><sec><title>Заключение</title><p>Заключение. Дисбиоз кишечника, вероятно, играет роль в формировании поздней идиопатической ЗРП. Уменьшение соотношения Firmicutes/Bacteroides, а также преобладание Actinobacteria отрицательно коррелируют с массой плода при рождении.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром поздней задержки роста плода</kwd><kwd>ЗРП</kwd><kwd>кишечный микробиом</kwd><kwd>осложнения беременности</kwd></kwd-group><kwd-group xml:lang="en"><kwd>late fetal growth retardation</kwd><kwd>FGR</kwd><kwd>intestinal microbiome</kwd><kwd>pregnancy complications</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации – Недостаточный рост плода, требующий предоставления медицинской помощи матери (задержка роста плода) – 2022-2023-2024 (14.02.2022). М.: Министерство здравоохранения Россиийской Федерации, 2022. 47 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/722_1. [Дата обращения: 14.07.2024].</mixed-citation><mixed-citation xml:lang="en">. Clinical guidelines – Insufficient fetal growth requiring maternalmedical care (fetal growth retardation) – 2022-2023-2024 (14.02.2022). [Klinicheskie rekomendacii – Nedostatochnyj rost ploda, trebuyushchij predostavleniya medicinskoj pomoshchi materi (zaderzhka rosta ploda) – 2022-2023-2024 (14.02.2022). Moscow: Ministerstvo zdravoohraneniya Rossiijskoj Federacii, 2022. 47 p. (In Russ.). Available at: https://cr.minzdrav.gov.ru/recomend/722_1. [Accessed: 14.07.2024].</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Centers for Disease Control and Prevention (CDC). World Health Organization, 2021. Режим доступа: https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/networks/vaccine-safety-net/vsn-members/centers-for-disease-controland-prevention. [Дата обращения: 14.07.2024].</mixed-citation><mixed-citation xml:lang="en">Centers for Disease Control and Prevention (CDC). World Health Organization, 2021. Available at: https://www.who.int/teams/regulationprequalification/regulation-and-safety/pharmacovigilance/networks/vaccine-safety-net/vsn-members/centers-for-disease-control-andprevention. [Accessed: 14.07.2024].</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">MacLeod R., Paulson J.N., Okalany N. et al. Intraventricular haemorrhage in a Ugandan cohort of low-birth weight neonates: the IVHU study. BMC Pediatr. 2021;21(1):12. https://doi.org/10.1186/s12887-020-02464-4.</mixed-citation><mixed-citation xml:lang="en">MacLeod R., Paulson J.N., Okalany N. et al. Intraventricular haemorrhage in a Ugandan cohort of low-birth weight neonates: the IVHU study. BMC Pediatr. 2021;21(1):12. https://doi.org/10.1186/s12887-020-02464-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dinu M., Stancioi-Cismaru A.F., Gheonea M. et al. Intrauterine growth restriction – prediction and peripartum data on hospital care. Medicina. 2023;59(4):773. https://doi.org/10.3390/medicina59040773.</mixed-citation><mixed-citation xml:lang="en">Dinu M., Stancioi-Cismaru A.F., Gheonea M. et al. Intrauterine growth restriction – prediction and peripartum data on hospital care. Medicina. 2023;59(4):773. https://doi.org/10.3390/medicina59040773.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplina A., Kononova S., Zaikova E. et al. Necrotizing enterocolitis: the role of hypoxia, gut microbiome, and microbial metabolites. Int J Mol Sci. 2023;24(3):2471. https://doi.org/10.3390/ijms24032471.</mixed-citation><mixed-citation xml:lang="en">Kaplina A., Kononova S., Zaikova E. et al. Necrotizing enterocolitis: the role of hypoxia, gut microbiome, and microbial metabolites. Int J Mol Sci. 2023;24(3):2471. https://doi.org/10.3390/ijms24032471.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandez-Rodriguez B., de Alba C., Galindo A. et al. Obstetric and pediatric growth charts for the detection of late-onset fetal growth restriction and neonatal adverse outcomes. J Perinat Med. 2020;49(2):216–24. https://doi.org/10.1515/jpm-2020-0210.</mixed-citation><mixed-citation xml:lang="en">Fernandez-Rodriguez B., de Alba C., Galindo A. et al. Obstetric and pediatric growth charts for the detection of late-onset fetal growth restriction and neonatal adverse outcomes. J Perinat Med. 2020;49(2):216–24. https://doi.org/10.1515/jpm-2020-0210.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32(3):213–8. https://doi.org/10.1053/j.semperi.2007.11.005.</mixed-citation><mixed-citation xml:lang="en">Ross M.G., Beall M.H. Adult sequelae of intrauterine growth restriction. Semin Perinatol. 2008;32(3):213–8. https://doi.org/10.1053/j.semperi.2007.11.005.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Børte S., Winsvold B.S., Stensland S.Ø. et al. The effect of fetal growth restriction on the development of migraine and tension-type headache in adulthood. The HUNT Study. PLoS One. 2017;12(4):e0175908. https://doi.org/10.1371/journal.pone.0175908.</mixed-citation><mixed-citation xml:lang="en">Børte S., Winsvold B.S., Stensland S.Ø. et al. The effect of fetal growth restriction on the development of migraine and tension-type headache in adulthood. The HUNT Study. PLoS One. 2017;12(4):e0175908. https://doi.org/10.1371/journal.pone.0175908.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hu J., Benny P., Wang M. et al. Intrauterine growth restriction is associated with unique features of the reproductive microbiome. Reprod Sci. 2021;28(3):828–37. https://doi.org/10.1007/s43032-020-00374-5.</mixed-citation><mixed-citation xml:lang="en">Hu J., Benny P., Wang M. et al. Intrauterine growth restriction is associated with unique features of the reproductive microbiome. Reprod Sci. 2021;28(3):828–37. https://doi.org/10.1007/s43032-020-00374-5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tu X., Duan C., Lin B. et al. Characteristics of the gut microbiota in pregnant women with fetal growth restriction. BMC Pregnancy Childbirth. 2022;22(1):297. https://doi.org/10.1186/s12884-022-04635-w.</mixed-citation><mixed-citation xml:lang="en">Tu X., Duan C., Lin B. et al. Characteristics of the gut microbiota in pregnant women with fetal growth restriction. BMC Pregnancy Childbirth. 2022;22(1):297. https://doi.org/10.1186/s12884-022-04635-w.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Miao T., Yu Y., Sun J. et al. Decrease in abundance of bacteria of the genus Bifidobacterium in gut microbiota may be related to pre-eclampsia progression in women from East China. Food Nutr Res. 2021;65. https://doi.org/10.29219/fnr.V65.5781.</mixed-citation><mixed-citation xml:lang="en">Miao T., Yu Y., Sun J. et al. Decrease in abundance of bacteria of the genus Bifidobacterium in gut microbiota may be related to pre-eclampsia progression in women from East China. Food Nutr Res. 2021;65. https://doi.org/10.29219/fnr.V65.5781.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Li G., Yin P., Chu S. et al. Correlation analysis between FGR and gut microbial composition in late pregnancy. J Diabetes Res. 2021;2021:8892849. https://doi.org/10.1155/2021/8892849.</mixed-citation><mixed-citation xml:lang="en">Li G., Yin P., Chu S. et al. Correlation analysis between FGR and gut microbial composition in late pregnancy. J Diabetes Res. 2021;2021:8892849. https://doi.org/10.1155/2021/8892849.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kyono K., Hashimoto T., Nagai Y., Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol. 2018;17(3):297–306. https://doi.org/10.1002/rmb2.12105.</mixed-citation><mixed-citation xml:lang="en">Kyono K., Hashimoto T., Nagai Y., Sakuraba Y. Analysis of endometrial microbiota by 16S ribosomal RNA gene sequencing among infertile patients: a single-center pilot study. Reprod Med Biol. 2018;17(3):297–306. https://doi.org/10.1002/rmb2.12105.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yao Y., Cai X., Chen C. et al. The role of microbiomes in pregnant women and offspring: research progress of recent years. Front Pharmacol. 2020;11:643. https://doi.org/10.3389/fphar.2020.00643.</mixed-citation><mixed-citation xml:lang="en">Yao Y., Cai X., Chen C. et al. The role of microbiomes in pregnant women and offspring: research progress of recent years. Front Pharmacol. 2020;11:643. https://doi.org/10.3389/fphar.2020.00643.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cadaret C.N., Posont R.J., Beede K.A. et al. Maternal inflammation at midgestation impairs subsequent fetal myoblast function and skeletal muscle growth in rats, resulting in intrauterine growth restriction at term. Transl Anim Sci. 2019;3(2):txz037. https://doi.org/10.1093/tas/txz037.</mixed-citation><mixed-citation xml:lang="en">Cadaret C.N., Posont R.J., Beede K.A. et al. Maternal inflammation at midgestation impairs subsequent fetal myoblast function and skeletal muscle growth in rats, resulting in intrauterine growth restriction at term. Transl Anim Sci. 2019;3(2):txz037. https://doi.org/10.1093/tas/txz037.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Железова М.Е., Бектур Б.K., Мальцева Л.И. и др. Значение материнского микробиома в развитии поздней задержки роста плода. Практическая медицина. 2022;20(5):34–9. https://doi.org/10.32000/2072-1757-2022-5-34-39.</mixed-citation><mixed-citation xml:lang="en">Zhelezova M.E., Bektur B.K., Maltseva L.I., et al. Influence of the maternal microbiome on the development of late fetal growth retardation. [Znachenie materinskogo mikrobioma v razvitii pozdnej zaderzhki rosta ploda]. Prakticheskaya medicina. 2022;20(5):34–9. (In Russ.). https://doi.org/10.32000/2072-1757-2022-5-34-39.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sokol H., Seksik P., Furet J.P. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–9. https://doi.org/10.1002/ibd.20903.</mixed-citation><mixed-citation xml:lang="en">Sokol H., Seksik P., Furet J.P. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009;15(8):1183–9. https://doi.org/10.1002/ibd.20903.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Дудун А.А., Бонарцев А.П., Жаркова И.Г., Воинова В.В. Роль кишечной микробиоты в лечении различных заболеваний и антибактериальные препараты нового поколения. Учебно-методическое пособие. М.: Мир науки, 2020. 129 с. Режим доступа: https://izd-mn.com/PDF/17MNNPU20.pdf. [Дата обращения: 14.07.2024].</mixed-citation><mixed-citation xml:lang="en">Dudun A.A., Bonartsev A.P., Zharkova I.G., Voinova V.V. The role of intestinal microbiota in the treatment of various diseases and new generation antibacterial drugs. Study guide. [Rol' kishechnoj mikrobioty v lechenii razlichnyh zabolevanij i antibakterial'nye preparaty novogo pokoleniya. Uchebno-metodicheskoe posobie]. Moscow: Mir nauki, 2020. 129 p. (In Russ.). Available at: https://izd-mn.com/PDF/17MNNPU20.pdf. [Accessed: 14.07.2024].</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mizgier М., Jarzabek-Bielecka G., Mruczyk K., Kedzia W. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women. Ginekol Pol. 2020;91(7):412–6. https://doi.org/10.5603/GP.2020.0070.</mixed-citation><mixed-citation xml:lang="en">Mizgier М., Jarzabek-Bielecka G., Mruczyk K., Kedzia W. The role of diet and probiotics in prevention and treatment of bacterial vaginosis and vulvovaginal candidiasis in adolescent girls and non-pregnant women. Ginekol Pol. 2020;91(7):412–6. https://doi.org/10.5603/GP.2020.0070.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Gorczyca K., Obuchowska A., Kimber-Trojnar Ż. et al. Changes in the gut microbiome and pathologies in pregnancy. Int J Environ Res Public Health. 2022;19(16):9961. https://doi.org/10.3390/ijerph19169961.</mixed-citation><mixed-citation xml:lang="en">Gorczyca K., Obuchowska A., Kimber-Trojnar Ż. et al. Changes in the gut microbiome and pathologies in pregnancy. Int J Environ Res Public Health. 2022;19(16):9961. https://doi.org/10.3390/ijerph19169961.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Koren O., Goodrich J.K., Cullender T.C. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. https://doi.org/10.1016/j.cell.2012.07.008.</mixed-citation><mixed-citation xml:lang="en">Koren O., Goodrich J.K., Cullender T.C. et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80. https://doi.org/10.1016/j.cell.2012.07.008.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zixin T., Yun Ch., Fang H. et al. Alterations in the gut microbiome and metabolisms in pregnancies with fetal growth restriction. Microbiol Spectr. 2023;11(3):e00076-23. https://doi.org/10.1128/spectrum.00076-23.</mixed-citation><mixed-citation xml:lang="en">Zixin T., Yun Ch., Fang H. et al. Alterations in the gut microbiome and metabolisms in pregnancies with fetal growth restriction. Microbiol Spectr. 2023;11(3):e00076-23. https://doi.org/10.1128/spectrum.00076-23.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jin J., Gao L., Zou X. et al. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res. 2022;131(6):492–506. https://doi.org/10.1161/CIRCRESAHA.122.320771.</mixed-citation><mixed-citation xml:lang="en">Jin J., Gao L., Zou X. et al. Gut dysbiosis promotes preeclampsia by regulating macrophages and trophoblasts. Circ Res. 2022;131(6):492–506. https://doi.org/10.1161/CIRCRESAHA.122.320771.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Salafia C.M., Ernst L.M., Pezzullo J.C. et al. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995;12(2):106–10. https://doi.org/10.1055/s-2007-994417.</mixed-citation><mixed-citation xml:lang="en">Salafia C.M., Ernst L.M., Pezzullo J.C. et al. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995;12(2):106–10. https://doi.org/10.1055/s-2007-994417.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Marcorelles P. Placental features in intrauterine growth retardation. J Gynecol Obstet Biol Reprod. 2013;42(8):996–1007. (In French). https://doi.org/10.1016/j.jgyn.2013.09.021.</mixed-citation><mixed-citation xml:lang="en">Marcorelles P. Placental features in intrauterine growth retardation. J Gynecol Obstet Biol Reprod. 2013;42(8):996–1007. (In French). https://doi.org/10.1016/j.jgyn.2013.09.021.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
